June 9, 2018 - Atlanta, GA - Results from a pivotal trial of PRO 140, a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic in combination with antiretroviral treatment (ART) for previously treated HIV-1 infected patients. This is an ongoing randomized, double-blind, placebo-controlled trial. The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology, held from June 7th to June 11th in Atlanta, GA.
A breakthrough new technique enables scientists to image 10,421 genes at once within individual cells.
The work was done in the laboratory of Long Cai, research professor in biology and an affiliated faculty member of the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech. A paper describing the research appears in the June 7 issue of the journal Cell.
Scientists are gaining a better understanding of Pierce's disease and how it affects grapevines. The disease, which annually costs California more than $100 million, comes from a bacterium called Xylella fastidiosa. While the bacterium has been present in the state for more than 100 years, Pierce's disease became a more serious threat to agriculture with the arrival of the glassy-winged sharpshooter insect, which can carry the bacterium from plant to plant.
June 8, 2018 - Thirteen years after the first successful face transplant, US trauma surgeons should be aware of the current role of facial transplantation for patients with severe facial disfigurement - including evidence that the final appearance and functioning are superior to that provided by conventional reconstructive surgery.
CORVALLIS, Ore. - Web page articles and other written materials designed to encourage physical activity are often too difficult to be easily read and understood by most U.S. adults, limiting their effectiveness, new research from Oregon State University shows.
As the 150th anniversary of the formulation of the Periodic Table of Chemical Elements looms, a Michigan State University professor probes the table's limits in a recent Nature Physics Perspective.
Washington DC (June 7, 2018) - The average pre-approval cost of research and development for a successful drug is estimated to be US$2.6 billion and the number of new drugs approved per billion US dollars spent has halved roughly every 9 years since 1950. More than 90% of drug candidates entering clinical trials fail to gain regulatory approval, mainly as a result of insufficient efficacy and/or unacceptable toxicity, because of the limited predictive value of preclinical, animal-based studies.
June 7, 2018 - Patients who take prescription opioids for a longer period before spinal surgery are more likely to continue using opioids several months after surgery, reports a study in the June 6, 2018, issue of The Journal of Bone & Joint Surgery.
Washington, DC-- NASA's Curiosity rover has discovered new "tough" organic molecules in three-billion-year-old sedimentary rocks on Mars, increasing the chances that the record of habitability and potential life could have been preserved on the Red Planet, despite extremely harsh conditions on the surface that can easily break down organic molecules.
Although the discipline of public health has recently recognized racism as a social determinant of health, little research examines the issue related to systems and structures.
University of Louisville School of Public Health and Information Sciences researcher Billie Castle, Ph.D., a post-doctoral associate in the Department of Health Promotion and Behavioral Sciences, conducted a literature review on the terms racism and systemic racism and found 85 published articles on the topic.